Alerts
Sorted by Date
- 02/24/2015
Spironolactone Combined with Sulfamethoxazole-Trimethoprim - Drug Interaction May Increase Risk of Sudden Death in Elderly
- 02/05/2015
Dietary Supplements Don’t Contain Active Ingredients – New York Attorney General Issues Cease and Desist Letters
- 01/22/2015
Practi-0.9‰ Sodium Chloride Training Intravenous Bags from Wallcur – Voluntary Recall Due to Serious Adverse Events UPDATED
- 12/26/14
Mitoxantrone 2 mg/mL Injection Vials from Hospira - Voluntary Recall Due to Reduced Potency and Increased Impurity
- 12/23/14
Probiotic Supplements and Risk of Invasive Fungal Disease in Immunocompromised Persons
- 12/15/14
Ziprasidone Associated with Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Skin Reactions
- 12/11/14
Alere INRatio Monitoring System and Strips Associated With Erroneous PT/INR Results
- 12/05/14
Dimethyl Fumarate (Tecfidera) –Progressive Multifocal Leukoencephalopathy Reported
- 11/21/14
Long-term Dual Antiplatelet Therapy - Possible Increased Risk of Noncardiovascular Death
- 11/21/14
Therapeutic Equivalence Rating Change of Generic Concerta (methylphenidate ER) Products
- 11/03/14
Avoid Using Ginseng Kianpi Pil from Kweilin Drug – Capsules May Contain Undeclared Corticosteroid and Antihistamine
- 10/03/14
Bo Ying Compound by Eu Yan Sang Ltd. Associated With Lead Poisoning
- 9/30/14
Omalizumab (Xolair) - Increased Risk of Serious Cardiovascular and Cerebrovascular Events
- 9/12/14
Disposal of Controlled Substances - New Rules
- 8/29/14
Hydrocodone Combination Products – Changed from Schedule III to Schedule II Controlled Substances - Updated
- 8/13/14
RegeneSlim Appetite Control Recall: Presence of DMAA in Capsules
- 7/22/14
Compounded Sterile Drug Product Recalls Regarding Sterility and Quality Control – UPDATED
- 06/30/2014
Injectable Vitamin Products: “Sunshine Labs” products distributed by Medical Supply Liquidators not FDA approved
- 06/26/2014
Viscous lidocaine 2% solution – Risk of serious adverse reactions, including death, when used for teething pain
- 06/26/2014
Over-The-Counter Topical Acne Products: Serious Allergic Reactions or Severe Irritation
- 06/25/2014
Olmesartan (Benicar®) and Increased Cardiovascular Events Safety Review – Updated
- 06/23/2014
Docetaxel Contains Ethanol: May Cause Intoxication Symptoms
- 05/19/2014
Eszopiclone (Lunesta) Dosing Change: Lower Recommended Doses
- 05/14/2014
Dabigatran – New Safety Data Comparing Dabigatran with Warfarin
- 04/30/2014
Flawless Beauty and Skin Recalls Multiple Unapproved Injectable Drug Products
- 04/28/2014
Super Arthgold from Nano Well-being Health Recalled – Capsules Contain Undeclared NSAIDs, Chlorzoxazone
- 04/28/2014
Disposal of Prescription Medications in the Community - Federal Guidelines - UPDATED
- 04/25/2014
Corticosteroids Administered Epidurally - Risk of Severe Neurologic Complications
- 04/02/2014
Orlistat Capsules (alli®) from GlaxoSmithKline Voluntarily Recalled – Bottles May Contain Other Tablets or Capsules
- 03/31/2014
Sildenafil (Revatio®) - Risk of Increased Mortality in Pediatric Patients - Updated
- 03/25/2014
Pleo Homeopathic Drug Products - Undeclared Penicillin
- 03/10/2014
Doripenem (Doribax®) – Possible Increased Risk of Death in Ventilator-Associated Pneumonia
- 03/07/2014
Pfizer Recalls Two Lots of Effexor XR and One Lot of Venlafaxine Extended Release Capsules for Potential of Tikosyn Capsules Found in Bottles
- 03/05/2014
Forest Discontinuing Namenda (Memantine) Immediate Release Tablets
- 02/18/2014
L-Citrulline by Medisca – Contaminated Product Contains N-Acetyl-Leucine
- 02/14/2014
Saxagliptin Products (Onglyza® and Kombiglyze™ XR) – Possible Heart Failure Association
- 02/12/2014
Testosterone Products and Risk of Heart Attack, Stroke, and Death
- 01/17/2014
Pro ArthMax Dietary Supplement- Undeclared Active Drug Ingredients
- 01/16/2014
Acetaminophen in Prescription Medications Limited to 325 mg per Dosage Unit - UPDATED
- 01/10/2014
Sodium Phosphate OTC Products – Risk of Serious Adverse Events due to Exceeding Recommended Dosing
- 12/27/2013
Ponatinib (Inclusig): Increased Reports of Arterial and Venous Blood Clots – Marketing Resumed – Update
- 12/27/2013
Mass Destruction Dietary Supplement - Linked to Serious Liver Injury
- 12/19/2013
Methylphenidate and Dexmethylphenidate - Risk of Priapism
- 12/04/2013
Hydroxyethyl Starch Solution – May cause increased mortality, risk of bleeding, and renal injury - UPDATED
- 12/04/2013
Clobazam (Onfi) - Labeling Revision Regarding Risk of Severe Life-Threatening Rash
- 12/03/2013
FreeStyle Lite and FreeStyle Test Strips Associated With Erroneously Low Blood Glucose Results
- 11/26/2013
Atropine/Pralidoxime (DuoDote®) Auto-Injector Extended Dating Allowed, Potential for Extended Dating for other Auto-Injectors by Meridian Medical
- 11/25/2013
Rosiglitazone (Avandia) – Not Associated with Cardiovascular Events – UPDATE
- 11/22/2013
Regadenoson (Lexiscan) and Adenosine (Adenoscan) - Risk of Heart Attack
- 11/18/2013
Over-the-Counter Topical Antiseptics - Label and Package Changes to Reduce Infection Risk
- 11/18/2013
Compounded Sterile Drug Product Recalls Regarding Sterility and Quality Control - UPDATED
- 11/13/2013
Low Molecular Weight Heparins - Label Changes to Decrease Spinal Column Bleeding and Paralysis Risks
- 11/11/2013
OxyElite Pro Dietary Supplement - Recall Due to Risk of Liver Injury - Updated
- 11/05/2013
Ezogabine (Potiga™) - Linked to Blue Skin Discoloration and Retinal Abnormalities – Update
- 10/02/2013
Ofatumumab (Arzerra®) and Rituximab (Rituxan®): Label Changes due to Risk of Hepatitis B Virus Reactivation
- 09/30/2013
Tygacil® (tigecycline) –New Boxed Warning Due to Increased Risk of Death
- 09/25/2013
Fentanyl (Duragesic®) Patches – Changes in Printing Ink on Patch to Improve Safety
- 09/13/2013
Opioid Long Acting and Extended Release Presentations – New Class Labeling Changes
- 09/04/2013
Fingolimod - FDA Investigating a Case of Progressive Multifocal Leukoencephalopathy
- 08/29/2013
Ortiga Contains Undeclared Diclofenac
- 08/22/2013
Fluoroquinolone (levofloxacin, moxifloxicin, ciprofloxacin, norfloxacin, ofloxacin, and gemfloxicin) – Label Changes Due to Risk of Disabling Peripheral neuropathy with oral and parenteral formulations
- 08/02/2013
Acetaminophen – May Cause Serious Skin Reactions
- 08/01/2013
Mefloquine hydrochloride: Labeling Changes Due to Neurologic and Psychiatric Effects
- 07/30/2013
Healthy Life Chemistry Dietary Supplement Contains Potentially Harmful, Undeclared Methasterone and Dimethazine
- 07/29/2013
Ketoconazole (Nizoral) Oral Tablets – Label Changes Due to Potentially Fatal Hepatotoxicity, Adrenal Insufficiency, and Risk of Drug Interactions
- 07/26/2013
Fastin (Phenylethylamine) Potential for Confusion with Prescription Medication Fastin (Phentermine)
- 07/26/2013
Illegally Marketed Diabetes Products
- 07/05/2013
Olmesartan medoxomil - Labeling Update to Include Sprue-Like Enteropathy
- 07/01/2013
Dietary Supplements for Erectile Dysfunction - Dangerous Ingredients - UPDATED
- 06/26/2013
Human Immune Globulin –Risk of Thrombosis with All Routes of Administration
- 06/19/2013
Olanzapine Pamoate (Zyprexa Relprevv) Safety Communication – FDA Investigating 2 Unexplained Deaths
- 06/04/2013
Improving Safety of Injection Practices
- 05/31/2013
Magnesium Sulfate Injection Not Recommended for Use in Preterm Labor
- 05/09/2013
Valproate Products Contraindicated in Pregnant Patients for Migraine Prophylaxis Due to Decreased IQ in Children Exposed In Utero
- 05/09/2013
The Compounding Shop Recalls All Sterile Compounded Products Due to Concerns Regarding Sterility and Quality Control
- 05/08/2013
Ado-Trastuzumab (Kadcyla) - Sound-Alike Look-Alike Confusion with Trastuzumab (Herceptin)
- 05/07/2013
Botulinum Toxin (Botox) – Foreign Unapproved Products Sold by “Online Botox Pharmacy”
- 05/07/2013
Tolvaptan (Samsca) Drug Warning: Labeling Changes Due to Risk of Hepatic Injury - UPDATE
- 04/30/2013
Saratoga Therapeutics LLC Recalls ebA Multivitamin Due To Undeclared Milk Products
- 04/30/2013
Piperacillin/Tazobactam for Injection 40.5 Grams Recall: Possible Precipitation or Crystallization of Some Lots
- 04/26/2013
Hospira Recalls One Lot of Sodium Chloride Injection 0.9%, 100 mL Flexible Containers
- 04/24/2013
Nora Apothecary & Alternative Therapies Recalls All Sterile Compounded Products Due to Concern Regarding Sterility and Quality Control
- 04/24/2013
LifeScan Recalls all OneTouch® Verio®IQ Blood Glucose Meters due to Defective Reporting of Extremely High Blood Glucose Levels
- 04/23/2013
Alaris PC Unit Software V9.12 used with EtCO2 Modules or SpO2 Modules – Class I Recall
- 04/22/2013
Balanced Solutions Compounding Pharmacy Recalls All Sterile Products Due to Concerns Regarding Sterility and Quality Control
- 04/18/2013
NuVision Pharmacy Recalls Lyophilized HcG and Sermorelin/GHRH6 Injectables Due to Concerns Regarding Sterility and Quality Control
- 04/18/2013
ApothéCure Recalls All Sterile Compounded Injectables Due to Concerns Regarding Sterility and Quality Control
- 04/12/2013
Green Valley Drugs Recalls All Sterile Compounded Products Due to Concerns Regarding Sterility and Quality Control
- 04/10/2013
Flolan® (epoprostenol sodium): Use 0.22 or 0.2 Micron Filter to Remove Glass Particles
- 04/09/2013
BIVIGAM Immune Globulin Intravenous (Human) Recall Due To Visible Particles
- 04/09/2013
Typographical Errors in the Handbook on Injectable Drugs – Esomeprazole Sodium Concentration Incorrect in Esomeprazole Sodium Monograph
- 04/02/2013
Hospira Recall of Sodium Chloride Injection 0.9%, 1,000 mL Flexible Containers
- 03/28/2013
Pallimed Solutions Recalls All Sterile Compounded Products Due To Visible Particulates
- 03/22/2013
Pfizer Issues Warning for Rifampin Injection – Discolored Product
- 03/21/2013
Clinical Specialties Compounding Pharmacy Recalls All Sterile Products - Potential for Lack of Sterility - UPDATED
- 03/20/2013
Incretin Memetic Drugs—Possible Increased Risk of Pancreatitis and Precancerous Pancreatic Cells
- 03/19/2013
GOPump Elastomeric Infusion PumpKit Recall - Displacement of Flow Restrictor Bead
- 03/19/2013
Med Prep Consulting Voluntarily Recalls All Compounded Injectable Products – Risk of Contamination
- 03/15/2013
Azithromycin (Zithromax®) - Risk of Arrhythmia and Cardiovascular Death - Updated
- 03/12/2013
Calcitonin Salmon - FDA Advisory Panel Recommends Against the Use of Calcitonin Salmon for Postmenopausal Osteoporosis.
- 03/05/2013
Cinacalcet hydrochloride (Sensipar) – Pediatric clinical trials suspended following reported death
- 03/04/2013
Peginesatide Injection (Omontys®) - All Lots Recalled Due to Hypersensitivity Reactions
- 02/20/2013
Cidofovir Injection (Vistide) – 1 Lot Recalled Due to Particulate Matter
- 02/06/2013
Bevacizumab (Altuzan) – Counterfeit Product UPDATED
- 01/29/2013
Hospira Recall of Lactated Ringer’s and 5% Dextrose Injection Expands to 2 Lots – Update
- 01/18/2013
Rugby Natural Iron Supplement (ferrous sulfate 325 mg) Tablets Recalled by Advance Pharmaceutical – May Contain Meclizine Tablets
- 01/16/2013
Zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist) Dosing Change: Lower Recommended Doses
- 01/11/2013
Mitomycin Solution for Ophthalmic Use (Mitosol)
Recalled by Mobius – May Not Be Sterile
- 12/24/2012
Dabigatran Etexilate Mesylate (Pradaxa®) - Contraindicated in Patients with Mechanical Heart Valves
- 12/24/2012
Qualitest Recall of Oversized Hydrocodone 10 mg/Acetaminophen 500 mg Tablets Expands to More Than 100 Lots and 3 Lots Repackaged by Mylan – UPDATE
- 12/21/2012
Telaprevir (Incivek) is Associated with Severe Skin Reactions When Used
in Combination with Peginterferon Alfa and Ribavirin for Hepatitis C
- 12/20/2012
Cranberry - Warfarin (Coumadin) Interaction has been Removed from Medication Guide
- 12/19/2012
Zicam Extreme Congestion Relief Nasal Gel Recalled
due to Presence of Burkholderia Cepacia
- 12/18/2012
Xyrem® (sodium oxybate) Updated Labeling – New Warnings and Contraindication
- 12/17/2012
Hospira Recall of Injectable Carboplatin Due to Presence of Drug Crystals
- 12/14/2012
Surgiflo® Hemostatic Products Recalled by Ethicon
- 12/13/2012
Varenicline (Chantix®) Safety Alert – Cardiovascular Adverse Events - UPDATE
- 12/10/2012
Protandim® Dietary Supplement Caplets Recalled
by LifeVantage - May Contain Metal Fragments
- 12/07/2012
Heparin Container Labeling Change – Revised Labels to
Prominently Display the Total Drug Strength in Container
- 12/06/2012
Ondansetron (Zofran, generic) and Risk of Abnormal
Heart Rhythms or QT prolongation – Updated
- 12/03/2012
Iopamidol Injection (Isovue FLS2) Prefilled Power
Injector Syringes Recalled by Bracco Diagnostics
- 11/29/2012
Atorvastatin Tablets Recalled by Ranbaxy Pharmaceuticals Inc. – May Contain Small Glass Particles
- 11/16/2012
Immune Globulin Intravenous (IGIV), Subcutaneous (SCIG), or Intramuscular
– Risk of Thrombosis or Hemolysis
- 11/13/2012
Baxter Buretrol Solution Set - Recall
- 11/05/2012
Dabigatran etexilate mesylate (Pradaxa®) – Ongoing Safety Review of
Post-Marketing Reports Related to Serious Bleeding Events - UPDATE
- 11/02/2012
Fungal Meningitis Outbreak from Intrathecal
Products at Compounding Pharmacy - UPDATED
- 11/01/2012
Ameridose, LLC Voluntarily Recalls All Products
- 10/26/2012
OTC Eye Drops and Nasal Sprays - Serious Adverse Events
from Accidental Ingestion by Children
- 10/26/2012
Bupropion (Budeprion) XL 300 mg Tablets – Generic
Not Bioequivalent to Wellbutrin XL 300 mg
- 10/03/2012
Typhoid Vi Polysaccharide Vaccine (Typhim Vi) –
Voluntary Recall of Prefilled Syringes and Multidose Vials
- 10/02/2012
Suboxone® (buprenorphine and naloxone) Sublingual Tablets:
Voluntary Discontinuation by Manufacturer
- 09/25/2012
Hydrocodone 10 mg/Acetaminophen 500 mg Tablets - Watson Recalls 2 Lots Due to Possibility of Oversized Tablets
- 09/21/2012
Pramipexole (Mirapex®) – Ongoing Safety Analysis and Possible Increased Risk of Heart Failure
- 09/20/2012
Dronedarone (Multaq®) – Two-fold Increased Risk of Death and Serious Adverse Events – Update
- 09/19/2012
Intestinomicina Safety Alert – Product Contains Chloramphenicol and Other Antibacterial Agents
- 09/14/2012
Topical Muscle and Joint Pain Relievers Associated with Chemical Burns
- 09/06/2012
I-FLOW ON-Q Pump with ONDEMAND Bolus Button Recall – Continuous Infusion Risk
- 09/05/2012
Nimodipine (Nimotop ®) Manufacturer Recall: Crystals in Capsule Fill Solution
- 08/31/2012
Automix Automated Nutrition Compounder Class I Recall: Potential for Fluid into Device Keypads
- 08/27/2012
Alaris CareFusion Pump - Recalls
- 08/22/2012
Reumofan Plus Tablets Contain Diclofenac Sodium, Methocarbamol, and Dexamethasone - UPDATED
- 08/21/2012
Propofol (Hospira) - Recall of Three Lots Due to Glass Vial Defect
- 08/20/2012
Codeine – Risk of Rare, Possibly Fatal Adverse Events in Pediatric Patients after Tonsillectomy and/or Adenoidectomy
- 08/17/2012
Hospira Hydromorphone Injection Recall Due to Potential Overfill
- 08/03/2012
Alaris CareFusion PC Unit – Recall Due to Error Code
- 08/02/2012
B. Braun Recalls Infusomat Space Infusion System
- 08/02/2012
Dukal Corporation Recall of Benzalkonium Chloride Products Due to Potential Contamination
- 07/26/2012
Dalfampridine (Ampyra®) – Increased Risk of Seizures
- 07/16/2012
Hospira Recall of Injectable Carboplatin, Cytarabine, Paclitaxel, and Methotrexate Due to Presence of Particulate Matter
- 07/13/2012
Risk of Invasive Staphylococcus aureus Infections with Improper use of Single-Dose Vials
- 07/11/2012
iFlora® Kids Multi-Probiotic® And iFlora™ 4-Kids Powder Dietary Supplements- Voluntary Recall Due to Potential for Salmonella Contamination Updated
- 07/10/2012
Opioid Long Acting and Extended Release Presentations – New Class-Wide Risk Management Program
- 07/06/2012
Leucovorin Calcium Injection from Bedford – Voluntary Recall Due To Particulate Matter
- 07/03/2012
Cataplex and Pancreatrophin Dietary Supplements – Voluntary Recall Due To Potential Salmonella Contamination
- 07/02/2012
Vecuronium Bromide Injection 20 mg Vial – Voluntary Recall Due To Particulate Matter
- 06/27/2012
Cefepime (Maxipime®) - Risk of Nonconvulsive Status Epilepticus
- 06/11/2012
Digestive 3-in-1 Health Liquid Dietary Supplement (Wellesse) - Voluntary Recall Due to Potential for Salmonella Contamination
- 06/07/2012
Levonorgestrel and Ethinyl Estradiol Tablets (Introvale®) – Voluntary Recall Due to Possible Flaw in Packaging
- 05/30/2012
Adderall (amphetamine/dextroamphetamine) 30 mg Tablets – Counterfeit Products Sold Containing Acetaminophen and Tramadol
- 05/29/2012
Abacus Total Parenteral Nutrition (TPN) Calculation Software from Baxa – Class I Recall Due to Potential for Dosing Errors
- 05/25/2012
Dialysate Concentrate Products Containing Acetate, Acetic Acid, Citrate – Dosing Errors
- 05/25/2012
Franck's Compounding - All Sterile Preparations - Do Not Use
- 05/23/2012
Hospira Carpuject Pre-filled Cartridges - Potential for Overfill - Visually Examine Prior to Administering
- 05/22/2012
Pancreatic Enzyme Products - New Products and Changes in Product Availability
- 05/16/2012
Fingolimod (Gilenya) and Risk of Death - Ongoing Safety Review and Revised Recommendations for Cardiovascular Monitoring
- 05/15/2012
Hydromorphone HCl Injection, 1 mg/1 mL Carpuject – Voluntary Recall Due to Potential for Excess Fill Volume
- 04/27/2012
Boceprevir (Victrelis) – Drug Interactions With Ritonavir-Boosted HIV Protease Inhibitors (Atazanavir, Darunavir, Lopinavir) – UPDATE
- 04/23/2012
Aliskiren-Containing Blood Pressure Medications: New Contraindication and Warning
- 04/20/2012
Fentanyl Transdermal Patch (Duragesic, generics) – Cautions About Accidental Exposure
- 04/18/2012
Morphine Sulfate Injection, 4 mg/1 mL Carpuject – Voluntary Recall Due to Potential for Excess Fill Volume
- 04/12/2012
Drospirenone-Containing Birth Control Pills – Labeling Changes for Possible Increased Risk of Venous Thromboembolic Events
- 03/29/2012
Citalopram hydrobromide (Celexa) and Abnormal Heart Rhythms: New Labeling Changes
- 03/23/2012
Argatroban Injection 50 mg/50mL - Voluntary Recall Due To Particulate Matter
- 03/22/2012
Campral® (Acamprosate) Recall – Tablets Failed Dissolution Test
- 03/16/2012
Skin Products May Contain Mercury, a Toxic Metal
- 03/14/2012
GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10%, 20g Recall – Labeling Error
- 03/13/2012
Fentanyl Transmucosal Products (Abstral, Actiq, Fentora, Lazanda, Onsolis; generics) – New Class-Wide Risk Management Program
- 03/01/2012
New Labeling Changes for Statin Drug Class and HIV and HCV C Medications – Drug Interactions
- 03/01/2012
New Labeling Changes for Statin Drug Class
- 03/01/2012
Lovastatin (Mevacor) Labeling Changes: New Drug Interactions & Dose Restrictions
- 02/27/2012
Norgestimate & Ethinyl Estradiol Tablets Recall – Potential for Incorrect Sequence of Tablets
- 02/24/2012
Phenylephrine Injection Recall from American Regent
- 02/24/2012
Cytarabine Injection Recall from Bedford Laboratories
- 02/17/2012
Tylenol Infant Formula Oral Suspension – Recall Due to SimpleMeasure Dosing System Problems
- 02/16/2012
Bevacizumab (Avastin®) – Counterfeit Product
- 02/13/2012
Koff and Kold and Kold Sore Products from Wholistic Herbs Inc Recalled – Non-Sterile Products
- 02/13/2012
Typographical Errors in the Handbook on Injectable Drugs - Furosemide Concentration Incorrect in Diazepam and Digoxin Monographs, Doxorubicin Stability Correction
- 02/09/2012
Proton Pump Inhibitors (PPIs) – May Increase Risk of Clostridium Difficile-Associated Diarrhea (CDAD)
- 02/01/2012
Norgestrel / Ethinyl Estradiol Tablets (Lo/Ovral®-28, generic) Recall – Potential for Wrong Tablet Count or Sequence
- 01/30/2012
Bendamustine Hydrochloride (Treanda®) Recall – Particulate Matter in Vial
- 01/30/2012
Merck Recalls Celestone® (Betamethasone) Oral Solution Due to Dosing Variability
- 01/30/2012
Teva Recalls Flutamide Capsules due to Potential Presence of Imatinib Mesylate Capsule
- 01/25/2012
Hospira recall of Sodium Chloride 0.9% and Lidocaine 0.4% in Dextrose 5%
- 01/24/2012
Doxazosin 4 mg Extended Release Tablets (Cardura XL) Recalled by Pfizer for Irregular 8-hour Dissolution Result
- 01/24/2012
Albuterol Inhaler (Ventolin HFA) Recalled by GlaxoSmithKline – May Contain Insufficient Propellant
- 01/23/2012
Topical Hair Regrowth Products from Perfect Images Solutions - Recalled Due to Presence of Unapproved Drugs
- 01/23/2012
Vagifresh Ball, Vagifresh Gel, and Female One - Products Recalled
- 01/23/2012
Natalizumab (Tysabri) Monotherapy and Progressive Multifocal Leukoencephalopathy
- 01/17/2012
Brentuximab Vedotin (Adcetris) – New Warnings About Progressive Multifocal Leukoencephalopathy and Pulmonary Toxicity
- 01/17/2012
Eribulin (Halaven) and Epirubicin (Ellence, generic) Name Confusion
- 01/12/2012
Bedford Laboratories Recall: Polymyxin B and Vecuronium
- 01/10/2012
Novartis Recall of Several Over-the-Counter Medications
- 01/09/2012
Opiate and Opiate-Containing Mix-ups with Endo Medications
- 01/06/2012
Selective Serotonin Reuptake Inhibitor (SSRI) Use During Pregnancy and the Risk of Persistent Pulmonary Hypertension of the Newborn (PPHN)
- 01/06/2012
Stimulant Medications for Attention-Deficit/Hyperactivity Disorder – Safety Review in Children and Young Adults – Update
- 12/28/2011
Methotrexate Injection – New Safety Labeling Changes
- 12/23/2011
New Infant Acetaminophen Concentration Available – Use Caution to Avoid Dosing Errors
- 12/23/2011
Motrin® IB (Ibuprofen) Caplets and Tablets - Recall Due To Dissolution Problems
- 12/23/2011
Gotu Kola (Centella asiatica) and Bladderwrack (Fucus vesiculosus) Dietary Supplement Recall – Potential Salmonella Contamination
- 12/16/2011
Simvastatin Products (Zocor, Vytorin, Simcor) and Muscle Injury: New Labeling Changes
- 12/14/2011
Stimulant Medications for Attention-Deficit/Hyperactivity Disorder – Cardiovascular Safety Review in Adults
- 12/09/2011
Romiplastim and Eltrombopag Risk Evaluation and Mitigation Strategy (REMS) Program
- 11/21/2011
Bevacizumab (Avastin) - FDA Removes Breast Cancer Indication
- 11/10/2011
Trilipix® (Fenofibric Acid) - Labeling Changes Due to Inability to Lower Risk of Cardiovascular Events in the ACCORD Trial
- 11/09/2011
Dabigatran (Pradaxa®) - Important Storage and Handling Requirements
- 11/04/2011
Anti-Tumor Necrosis Factor (TNF) Agents (adalimumab [Humira], certolizumab pegol [Cimzia], etanercept [Enbrel], infliximab [Remicade], golimumab [Simponi]) -Ongoing Safety Review of Malignancy Risk
- 11/04/2011
Anti-Tumor Necrosis Factor (TNF) Agents (adalimumab [Humira], certolizumab pegol [Cimzia], etanercept [Enbrel], infliximab [Remicade], golimumab [Simponi]), azathioprine, and mercaptopurine - Reports of Hepatosplenic T-Cell Lymphoma
- 10/25/2011
Drotrecogin alfa (Xigris) - Withdrawn From Worldwide Market
- 10/24/2011
Oxymetazoline (Nostrilla®) Nasal Decongestant - Recall Due to Possible Bacterial Contamination
- 10/21/2011
Methylene blue and Psychiatric Medication interactions
- 10/21/2011
Zyvox (linezolid) and Psychiatric Medications Interaction
- 10/12/2011
Dasatinib (Sprycel) May Increase Risk of Pulmonary Arterial Hypertension
- 09/19/2011
Qualitest Pharmaceuticals Oral Contraceptives - Recall Due to Packaging Error
- 09/08/2011
Tumor Necrosis Factor-alpha Blockers - Boxed Warnings Updated with Information on Legionella and Listeria Infection Risk
- 09/02/2011
Asenapine and Serious Hypersensitivity Reactions
- 09/02/2011
Zoledronic Acid Contraindicated in Patients with Renal Dysfunction
- 09/01/2011
Bevacizumab (Avastin®) Repackaged Intravitreal Injections - Risk of Serious Infections
- 08/29/2011
Povidone Iodine Products - Recall Due to Inadequate Microbial Testing
- 08/24/2011
Galactose, Maltose, and Xylose Products May Falsely Elevate Glucose Results
- 08/04/2011
Vasopressin Injection USP, Multiple Dose Vials - Voluntary Recall Due to Potential for Reduced Potency
- 08/04/2011
Fluconazole (Diflucan®): Chronic, High-Dose Therapy May be Associated with Birth Defects
- 07/22/2011
Oral Osteoporosis Drugs (Bisphosphonates): Drug Safety Communication - Potential Increased Risk of Esophageal Cancer
- 07/14/2011
Colistimethate Injection- Risk of Serious or Fatal Dosing Errors
- 07/13/2011
Oseltamivir (Tamiflu®) Oral Suspension- Labeling Change to Reflect New Concentration (6 mg/mL)
- 07/08/2011
Belatacept (Nulojix): REMS Required Due to Post-Transplant Lymphoproliferative Disorder and Progressive Multifocal Leukoencephalopathy
- 07/01/2011
Valproate Products and Risk of Impaired Cognitive Development in Children Due to Prenatal Exposure
- 07/01/2011
Tylenol® Extra Strength Caplets - Recall Due To Unusual Odor
- 06/29/2011
Nature Relief Instant Wart and Mole Remover - Recall Due to Risk of Serious Skin Burns
- 06/27/2011
Oxycodone 10 mg / Acetaminophen 325 mg Tablets (Endocet 10 mg / 325 mg) from Endo Recalled - Bottles May Contain Different Tablet Strengths
- 06/27/2011
Butalbital / Acetaminophen / Caffeine Tablets and Hydrocodone / Acetaminophen Tablets from Qualitest - Recall Due To Potential Mislabeling
- 06/27/2011
Erythropoiesis-Stimulating Agents (Darbepoetin alfa [Aranesp], Erythropoietin alfa [Epogen, Procrit]) - Proposed Changes in Product Labeling for Kidney Disease
- 06/21/2011
Risperidone and Risperdal® - Recall Due To Unusual Odor
- 06/16/2011
Indomethacin for Injection by Bedford - Voluntary Recall of a Single Lot
- 06/16/2011
Risperidone (Risperdal) and Ropinirole (Requip) - Medication Errors Due to Name Confusion
- 06/14/2011
Liraglutide [rDNA origin] (Victoza)- Risk of Acute Pancreatitis and Thyroid C-cell Tumors
- 06/13/2011
5-alpha Reductase Inhibitors (5-ARIs) Label Update - Increased Risk of Prostate Cancer
- 06/06/2011
Aidapack Services - Recall of Repackaged Products Due To Possible Beta-Lactam Cross Contamination
- 06/03/2011
Angiotensin Receptor Blockers and Safety Review for Cancer Risk
- 06/01/2011
Drospirenone-Containing Birth Control Pills - Ongoing Safety Review for Increased Risk of Venous Thromboembolic Events
- 05/24/2011
SimplyThick® - Necrotizing Enterocolitis in Premature Infants
- 05/24/2011
Pentrexyl Forte Natural Supplements - Recall Due To Misleading Packaging
- 05/12/2011
Multi-Mex Dietary Supplements - Recall Due To Misleading Names and Packaging
- 05/06/2011
Pre-filled Glass Syringes - Compatibility Problems with Needless Intravenous Access Systems
- 05/05/2011
Warfarin 5 mg tablets - Voluntary Recall of a Single Lot of Coumadin 5 mg Tablets
- 04/22/2011
Potassium Phosphates Injection - Recall Due to Particulates, Filter Non-Recalled Lots
- 04/15/2011
Lansoprazole Delayed-Release Orally Disintegrating Tablets from Teva - Withdrawn for Clogging Oral Syringes and Feeding Tubes
- 04/15/2011
Topiramate (Topamax) 100 mg tablets - Recall Due to Musty Odor
- 04/11/2011
Lenalidomide (Revlimid): Ongoing Safety Review for Increased Malignancy Risk
- 04/08/2011
Benzocaine Sprays, Gels and Liquids: Increased Risk of Methemoglobinemia
- 04/06/2011
Ipilimumab (Yervoy) and Serious Immune Mediated Adverse Reactions
- 03/29/2011
Soladek Vitamin Solution May Contain Toxic Amounts of Vitamins A and D
- 03/29/2011
Citalopram and Finasteride by Greenstone - Recalled due to Mislabeling
- 03/28/2011
Irinotecan Hydrochloride Injection - Recall Due to Fungal Contamination
- 03/23/2011
Fluoroquinolones Boxed Warning: Myasthenia Gravis
- 03/22/2011
Povidone Iodine Prep Pads - Recall Due to Possible Microbial Contamination
- 03/21/2011
Dexamethasone Sodium Phosphate 4 mg/mL Injection from American Regent - Recall Due to Particulates
- 03/21/2011
Concentrated Sodium Chloride Injection 23.4% from American Regent - Recall Due to Particulates
- 03/21/2011
Bacteriostatic Sodium Chloride Injection 0.9% from American Regent - Recall Due to Particulates
- 03/18/2011
Morphine Sulfate/Naltrexone HCl (Embeda®) - Voluntary Recall Due to Stability Concerns
- 03/16/2011
Potassium Iodide - Recommendations for Use After Radiation Exposure
- 03/09/2011
Lopinavir/Ritonavir (Kaletra) Oral Solution - Warning Added to Label: Risk of Serious Adverse Events in Premature Babies
- 03/07/2011
Topiramate (Topamax) - Use During Pregnancy May Increase Risk of Cleft Lip or Cleft Palate
- 03/07/2011
Abacavir and Didanosine and Potential Risk of Heart Attack - Ongoing Safety Review
- 03/02/2011
Proton Pump Inhibitors-Risk for Low Magnesium Levels with Prolonged Use
- 03/02/2011
FDA Removes Unapproved Cough, Cold, and Allergy Products from U.S. Market
- 02/24/2011
Warfarin Sodium (Jantoven) 3 mg Tablets - Upsher-Smith Recall Expanded to Include Amantadine, Amlodipine, Baclofen, Bethanecol, Fluoxymesterone (Androxy), Oxybutynin, and Warfarin
- 02/23/2011
Antipsychotic Class Labeling Update: Pregnancy Sections Revised to Include Risk of Extrapyramidal Signs and Withdrawal Symptoms in Newborns
- 02/22/2011
Golimumab (Simponi) Injection - Recall Due to Malfunctioning Autoinjector
- 02/22/2011
Linezolid (Zyvox) - Intravenous injection transitioning to Freeflex® IV bag
- 02/22/2011
Terbutaline Injection and Tablets- New Contraindication for Prolonged Treatment of Preterm Labor
- 02/17/2011
Sterile Lubricating Jelly - Recall Due to Potentially Unsterile Product
- 02/17/2011
Paliperidone palmitate (Invega Sustenna) - Recall Due to Cracks in Syringes
- 02/17/2011
Alcohol Prep Pads, Swabs, and Swabsticks - Recall Due to Possible Microbial Contamination
- 02/08/2011
Hydrocodone with Acetaminophen Tablets and Phenobarbital Tablets (Qualitest Pharmaceuticals) - Recall Due to Incorrect Labeling
- 02/07/2011
Sodium Thiosulfate Injection - Recall Due to Particulates
- 02/07/2011
Potassium Phosphates Injection - Recall Due to Particulates
- 01/19/2011
Dronedarone (Multaq): Potential for Severe Liver Injury
- 01/12/2011
Morphine Sulfate Oral Solution - Reports of Accidental Overdose Due to Medication Use Error
- 01/07/2011
Metronidazole 250 mg Tablets by Teva - One Lot Recalled Due to Underweight Tablets
- 01/04/2011
Albuterol Sulfate 0.083% Inhalation Solution by Ritedose Corporation - Recall Due to Mislabeled Vials
- 01/03/2011
Acetylcysteine Injection (Acetadote) - Recall Due to Particulates
- 12/29/2010
Sodium Bicarbonate Injection - Recall Due to Particulates
- 12/28/2010
Dexamethasone Sodium Phosphate Injection, 4 mg/mL, 30 mL Multiple Dose Vials Recalled - Particulates in Product
- 12/27/2010
Fluvirin (Influenza Virus Vaccine) Recall
- 12/27/2010
Weight Loss Products Containing Undeclared Active Ingredients
- 12/23/2010
Abbott Glucose Test Strips - Recall Due to Incorrect Results
- 12/23/2010
Human Growth Hormone, Recombinant (somatropin) - FDA Review for Increased Risk of Death
- 12/20/2010
Transdermal Patches with Metallic Backings - Risk of Burns if Worn During Magnetic Resonance Imaging Scans
- 12/20/2010
Avastin® (bevacizumab) - FDA Proposes Removal of Breast Cancer Indication
- 12/17/2010
Dolasetron Safety Announcement
- 12/14/2010
Benzonatate (Tessalon) - Potential for Accidental Overdose by Children
- 12/14/2010
Rolaids Extra Strength Softchews, Rolaids Extra Strength Plus Gas Softchews, and Rolaids Multi-Symptom plus Anti-Gas Softchews Recalled - Foreign Materials in Product
- 12/14/2010
Guaifenesin Over-The-Counter Tablets - Recall Due to Mislabeling
- 12/08/2010
Vasopressin injection - Typographical Error in the Handbook on Injectable Drugs
- 11/22/2010
Propoxyphene Products (Darvon, Darvocet) - Withdrawn From the Market
- 11/19/2010
Clopidogrel Bisulfate (Plavix) - Potential Interactions with Omeprazole (Prilosec) and Esomeprazole (Nexium) - Ongoing Safety Review
- 11/02/2010
Heparin Sodium - Voluntary Recall of 7 lots of B. Braun Heparin Products
- 11/01/2010
Methotrexate Injection Recalled - Potential Glass Particulates In Vials
- 10/25/2010
Hyland's Teething Tablets Recalled - Potential Risk of Harm to Children
- 10/22/2010
Saquinavir (Invirase) and Ritonavir (Norvir): Potential Risk of Cardiac Arrhythmias
- 10/22/2010
Fentanyl 25 mcg/hr Patch from Actavis - Recall
- 10/21/2010
Gonadotropin-Releasing Hormone (GnRH) Agonists - Diabetes and Cardiovascular Risk with Goserelin (Zoladex), Histrelin (Vantas), Leuprolide (Eligard, Lupron, Viadur), Nafarelin (Synarel), and Triptorelin (Trelstar)
- 10/20/2010
McNeil Consumer Healthcare Recall of OTC Products Due to Possible Chemical ContaminationD
- 10/18/2010
Over-the-Counter (OTC) Chelated Products - FDA Warns Against Use
- 10/14/2010
Oral Bisphosphonates and Hip Fracture - Alendronate (Fosamax), Ibandronate (Boniva), Risedronate (Actonel), Zoledronic Acid (Reclast) (Update)
- 10/11/2010
Sibutramine Hydrochloride (Meridia) Withdrawn from Market Due to Increased Risk of Cardiovascular Events
- 10/08/2009
Duloxetine (Cymbalta®) 5/Exacerbate Hepatic Injury in Patients with Preexisting Liver Disease
- 09/29/2010
Epogen® and Procrit® (Epoetin Alfa) - Recall
- 09/27/2010
Similac (Abbott) Powder Infant Formulas - Recall
- 09/24/2010
Octagam (Immune Globulin Intravenous 5% Liquid) Market Withdrawal
- 9/20/2010
Recall of Dietary Supplement Products Containing Aromatase Inhibitors
- 9/20/2010
Pioglitazone (Actos): Ongoing Safety Review for Increased Risk of Bladder Cancer
- 9/16/2010
Valganciclovir (Valcyte) - New Pediatric Dosing Recommendations
- 9/10/2010
Gadolinium-Containing Contrast Agents (Omniscan®, OptiMARK®, Magnevist®, Eovist ®, Ablavar®, ProHance®, MultiHance®) and Serious Nephrogenic Fibroses
- 09/10/2010
Midodrine (ProAmatine, generic) Proposed Market Withdrawal
- 09/02/2010
Tigecycline (Tygacil) and Increased Mortality Risk
- 08/23/2010
Entacapone/carbidopa/levodopa (Stalevo): Ongoing Cardiovascular Safety Review
- 08/13/2010
Lamotrigine (Lamictal) and Aseptic Meningitis
- 08/03/2010
NeoProfen (ibuprofen lysine) injection (Lundbeck) - Recall of Two Lots Due to Presence of Particulate Matter
- 08/02/2010
Nimodipine capsules warning: Do not give parenterally
- 08/02/2010
Influenza Virus Vaccine (Afluria®) - Risk of Febrile Events
- 08/02/2010
Miracle Mineral Solution (MMS) - Produces Harmful Chlorine Dioxide when Mixed as Directed with Citrus Juice
- 07/30/2010
Estradiol Transdermal Spray (Evamist): Unintended Exposure by Children and Pets
- 07/29/2010
Daptomycin (Cubicin) - Risk of Eosinophilic Pneumonia
- 07/19/2010
Advair Diskus (Fluticasone Propionate and Salmeterol Powder for Inhalation) Stolen - Verify Drug Pedigrees
- 07/14/2010
Warfarin (Coumadin) 1 mg Tablets in Blister Packs - Recall
- 07/14/2010
Leflunomide (Arava) and Risk of Severe Liver Injury
- 07/09/2010
Que She Dietary Supplement Contains Undeclared Sibutramine, Fenfluramine, Propranolol, and Ephedrine
- 07/09/2010
Quinine (Qualaquin) and Serious Hematologic Reactions
- 06/23/2010
Gemtuzumab Market Withdrawal
- 06/18/2010
Oseltamavir (Tamiflu) Counterfeit Products Sold on Internet
- 06/16/2010
Vitamin D Supplements - Dosing Errors in Infants
- 06/11/2010
Liposyn II and Liposyn III (Hospira) - Recall of Additional Lots Due to Presence of Particulate Matter
- 06/11/2010
Propofol (Hospira) - Recall of Additional Lots Due to Presence of Particulate Matter
- 06/07/2010
GammaGard Liquid Recall
- 06/01/2010
PediaCare Children's Products from Blacksmith Brands - Recall
- 06/01/2010
Intravenous Ciprofloxacin, Metronidazole, and Ondansetron Injection Made by Claris Lifesciences - Recall
- 05/27/2010
Hylenex Injection from Baxter Healthcare - RecallD
- 05/27/2010
Fosphenytoin Sodium Injection from Hospira- Recall
- 05/26/2010
Orlistat (Xenical and Alli) and Severe Liver Injury
- 05/26/2010
Proton Pump Inhibitors (PPI) and Risk of Fracture: Class Labeling Change
- 05/25/2010
Tramadol (Ultram, Ultracet) - Label Updates
- 05/24/2010
Schedule II Controlled Substances - Changes a Pharmacist May Make to Written Prescriptions - Utah Law Update
- 05/18/2010
Metronidazole Injection from Sagent Pharmaceuticals - Recall
- 05/18/2010
Rotarix (Rotavirus Vacine, Live, Oral) - FDA Recommends Resuming Use
- 05/14/2010
Eltrombopag (Promacta®) - Portal Venous System Thromboses in Patients with Chronic Liver Disease
- 05/14/2010
Benadryl Extra Strength Itch Stopping Gel - "For Skin Use Only" Added to Prominent Areas of the Product
- 05/05/2010
Naltrexone Extended-Release Injectable Suspension (Vivitrol) - Injection Site Reactions and New Medication Guide Requirement UPDATE
- 05/03/2010
Over-The-Counter Infants' and Children's Products - Voluntary Recall by McNeil Consumer Healthcare
- 05/03/2010
Vita Breath Dietary Supplement - May Contain Hazardous Lead Concentrations
- 04/26/2010
Propylthiouracil (PTU) - Risk of Hepatotoxicity
- 04/08/2010
Heparin: Change in Reference Standard- New Universal Standardization in Heparin Potency
- 04/08/2010
Over-The-Counter Camolyn Eye Drops And Fisiolin Nasal Drops - Recall For Possible Sterility Problems
- 04/05/2010
Entacapone/carbidopa/levodopa (Stalevo): Ongoing Prostate Cancer Safety Review
- 03/25/2010
Epoetin alfa, Darbepoetin alfa: New Risk Management Program
- 03/19/2010
Clevidipine Butyrate Injection (Cleviprex) - Recall
- 03/15/2010
Clopidogrel Bisulfate (Plavix) -Box Warning on Poor Metabolizers
- 03/11/2010
Rho(D) Immune Globulin Intravenous (Human) (WinRho SDF) Black Box Warning of Intravascular Hemolysis
- 03/05/2010
Dexlansoprazole (Kapidex) - Brand Name Change, Confusion with Casodex and Kadian
- 03/02/2010
Blood Glucose Test Strip Recall - OneTouch® SureStep® Test Strips
- 02/23/2010
Ear Candles - Risk of Serious Injuries, Avoid Use
- 02/23/2010
Long-Acting Beta-2 agonists (Formoterol [Foradil Aerolizer], Formoterol/Fluticasone [Symbicort], Salmeterol [Serevent Diskus], Salmeterol/Fluticasone [Advair Diskus, Advair HFA]) - New Requirements for Use in Asthma
- 02/23/2010
Deferasirox (Exjade) - New Boxed Warning about Potentially Fatal Renal, Hepatic, Hematologic, and Allergic Events
- 02/18/2010
Maalox Brand Products and Potential for Medication Errors
- 02/05/2010
Clindamycin Injection - APP Pharmaceuticals Recalls 11 Lots
- 02/03/2010
Daytrana (Methylphenidate) Patch - Recall of Specific Lots by Shire Pharmaceuticals
- 02/01/2010
Olanzapine (Zyprexa, Zyprexa Zydis) - Use with Caution in Adolescents
- 02/01/2010
Didanosine (Videx, Videx EC) and Non-Cirrhotic Portal Hypertension
- 01/27/2010
Bortezomib (Velcade) - Dose Adjustment in Hepatic Impairment
- 01/26/2010
Orlistat (Alli) -- Counterfeit Capsules
- 01/19/2010
Body Building Products Containing Unapproved Synthetic Steroids - FDA Issues Warning
- 01/15/2010
H1N1 Monovalent Vaccine Live 2009 (Intranasal) -Revised Expiration Dating
- 01/13/2010
Sirolimus (Rapamune®) - Effect of Different Assays on Therapeutic Drug Monitoring
- 01/04/2010
Nzu Dietary Supplements for Morning Sickness Contain Arsenic and Lead
- 12/24/2009
Simvastatin/Ezetimibe (Vytorin) and Ezetimibe (Zetia) and Increased Risk for Cancer of Safety Review
- 12/24/2009
Sanofi Pasteur Pediatric H1N1 Vaccine in Pre-filled Syringes - Non-Safety-Related Voluntary Recall
- 12/09/2009
Alka-Seltzer Plus Day & Night Cold Formula - Recall of a Single Lot by Bayer Consumer Care
- 12/07/2009
Diclofenac Topical Gel 1% (Voltaren Gel) and Hepatic Toxicity
- 12/04/2009
Fosamprenavir (Lexiva) - Increased Risk of Myocardial Infarction and Dyslipidemia
- 12/04/2009
Valproic Acid Derivatives (valproate sodium [Depacon], valproic acid [Depakene, Stavzor], divalproex sodium [Depakote, Depakote CP, Depakote ER]) and Birth Defect Risk
- 12/03/2009
Desipramine (Norpramin®) - New Warnings in Patients with a Family History of Cardiac Disorders
- 12/01/2009
Peramivir Injection - Emergency Use Authorization for H1N1 Influenza
- 11/20/2009
Vicks Sinex Nasal Spray - Recall of Specific Lots by Procter & Gamble
- 11/17/2009
Chondrolysis Associated with Continuously Infused Local Anesthetics [bupivacaine (Marcaine; Sensorcaine); chloroprocaine (Nesacaine); lidocaine (Xylocaine); mepivacaine (Carbocaine; Polocaine); procaine (Novocain); ropivacaine (Naropin)]
- 11/16/2009
Genzyme Products including alglucosidase alfa (Myozyme), algasidase beta (Fabrazyme), imiglucerase (Cerezyme), laronidase (Aldurazyme), and thyrotropin alfa (Thyrogen) - Possible Particulate Matter Contamination
- 11/13/2009
Pai You Guo Dietary Supplement Contains Undeclared Sibutramine and Phenolphthalein
- 11/11/2009
Interferon Alfa-2b (Intron A) Injection Pens - Recall of Several Lots by Schering-Plough
- 11/06/2009
Remifentanil Hydrochloride (Ultiva) - Typographical Error in the Handbook on Injectable Drugs
- 11/03/2009
Exenatide (Byetta®) - Altered Kidney Function Reported
- 10/28/2009
Accusure Insulin Syringe Recalld
- 10/26/2009
Rituximab (Rituxan®) and Progressive Multifocal Leukoencephalopathy (PML)
- 10/22/2009
Ketorolac Tromethamine Injection - Voluntary Recall
- 10/20/2009
Iron dextran injection (Dexferrum) - Black Box Warning for Potentially Fatal Anaphylactic Reaction
- 10/09/2009
Zanamivir (Relenza) - Potentially Fatal if Nebulized
- 10/08/2009
Ibritumomab tiuxetan (Zevalin) and Rituximab (Rituxan) - Potentially-fatal Skin and Mucus Membrane Reactions
- 10/08/2009
Able Laboratories Inc. - Recalls All Products/Suspends Manufacturing
- 10/01/2009
Acetaminophen (Tylenol®) Pediatric Liquid Products Recalled Due to Possible Bacterial ContaminationD
- 09/29/2009
Sitagliptin (Januvia) and sitagliptin/metformin (Janumet) - Reports of Acute Pancreatitis
- 09/29/2009
Oseltamivir (Tamiflu) Oral Suspension-Potential for Dosing Errors
- 09/25/2009
FDA Warns Pharmacies Against Compounding Topical Anesthetic Creams and Other Products
- 09/17/2009
Promethazine Hydrochloride Injection - Black Box Warning for Severe Tissue Injury
- 09/09/2009
Mycophenolic Acid (Myfortic®) - warning for risk of Pure Red Cell Aplasia (PRCA)
- 09/03/2009
Etravirine (Intelence™): Severe Skin and Hypersensitivity Reactions
- 08/26/2009
Insulin Detemir (Levemir) - Stolen Vials Resurface, Product Potentially Defective
- 08/26/2009
Ibuprofen topical OTC formulations marketed unlawfully - Warning letters issued by the FDA
- 08/18/2009
Dextroamphetamine/Amphetamine 20 mg Tablet Recall by Barr
- 08/17/2009
Correction Notice - Typographical Errors in Pediatric Injectable Drugs, 8th Edition (The Teddy Bear Book)
- 08/17/2009
Mycophenolate Mofetil (CellCept®) associated with Pure Red Cell Aplasia (PRCA)
- 08/11/2009
Midazolam Hydrochloride and Furosemide - Potential for Error
- 08/07/2009
Alaris System Class I Recall
- 08/07/2009
Erythropoiesis-Stimulating Agents (Darbepoetin alfa [Aranesp], Erythropoietin alfa [Epogen, Procrit]) - Proposed Changes in Product Labeling
- 08/06/2009
Magnesium Sulfate and Potassium Phosphate - Potential for Error
- 08/04/2009
Botulinum Toxin Types A (Botox, Botox Cosmetic, Dysport) and Botulinum Toxin Type B (Myobloc) - Safety Review Update and Names Changed to OnabotulinumtoxinA (Botox, Botox Cosmetic), AbobotulinumtoxinA (Dysport), and RimabotulinumtoxinB (Myobloc)
- 08/03/2009
Oral Colchicine (Colcrys) - Severe Drug Interactions with Strong CYP3A4 and P-glycoprotein Inhibitors
- 07/28/2009
Electronic Cigarette - A Potential Health Hazard
- 07/27/2009
Sanofi-Aventis Medications Stolen - Verify Drug Pedigrees
- 07/23/2009
Astellas Recall of Lots of Several Medications Due to Stolen Transport Trailer
- 07/20/2009
Prevnar (Pneumococcal 7-valent Conjugate) Vaccine Recall
- 07/17/2009
Propofol (Teva) - Recall of Two Lots Due to Presence of Endotoxin
- 07/16/2009
Omalizumab (Xolair®) - Ongoing Safety Review Update
- 07/16/2009
Acetaminophen Concentrated Drops - Brookstone Pharmaceuticals Voluntary Recall Due to Packaging Concerns
- 07/16/2009
Immunosuppressant Drugs - Labeling Changes Warning of Increased Risk of Opportunistic Infections
- 07/13/2009
Sodium Chromate Cr-51 Injection Recall
- 07/10/2009
Stealth Powdered Dietary Supplements - Recall due to possible Salmonella
- 07/06/2009
Creon - Newly Approved Formulation Requires New Prescription
- 07/06/2009
Bupropion (Zyban and generics) - Neuropsychiatric Events and Suicidality Warnings added to the Prescribing Information
- 07/01/2009
Insulin Glargine (Lantus) - Risk of Cancer
- 07/01/2009
Varenicline (Chantix) - Neuropsychiatric Events and Suicidality Warnings added to the Prescribing Information
- 07/01/2009
Acetaminophen - FDA Actions to Prevent Overdose
- 06/30/2009
Caraco Medications Seized by US Marshals Due to Ongoing Quality Problems UPDATED
- 06/30/2009
Tumor Necrosis Factor (TNF) Blocking Agents (adalimumab [Humira], certolizumab pegol [Cimzia], etanercept [Enbrel], golimimumab [Simponi], infliximab [Remicade])-Risk of Delayed Diagnosis of Opportunistic Infections
- 06/29/2009
Topical Anesthetic Agents for Medical and Cosmetic Procedures - Potentially Fatal Adverse Effects UPDATED
- 06/24/2009
“Total Body Formula” and “Total Body Mega Formula”- High Selenium Concentrations UPDATED
- 06/18/2009
Cefepime (Maxipime) - Ongoing Safety Reviewd
- 06/16/2009
Zicam Cold Remedy Nasal Products Associated with Loss of Sense of Smell
- 06/15/2009
Sirolimus (Rapamune®) - Safety in Liver Transplant Patients
- 06/12/2009
Montelukast (Singulair) and Risk of Behavior Changes, Mood Changes, or Suicidality - Ongoing Safety Review
- 06/11/2009
Clarcon Hand Sanitizers and Skin Protectants Recall
- 06/03/2009
ACCU-CHEK Softclix Lancet Recall
- 05/19/2009
Utah Medicaid Preferred Drug List Update
- 05/13/2009
Digoxin Tablet Recall by CaracoD
- 05/08/2009
Erlotinib (Tarceva) and New Safety Information
- 05/08/2009
Testosterone Gel Products and Inadvertent Exposure in Children
- 05/06/2009
Antiepileptic Drugs and Increased Risk of Suicidal Behavior or Suicidal Ideation
- 05/04/2009
Hydroxycut Consumer Warning and Product Recall
- 04/29/2009
Non-Acetone Nail Polish Remover (Personal Care Products) - Recall, Potential for Chemical Burns
- 04/14/2009
Ceftriaxone Injection (Rocephin) - Interaction with Calcium Products and New Contraindication in Hyperbilirubinemic Neonates
- 04/13/2009
Efalizumab (Raptiva®) withdrawal
- 03/25/2009
Propafenone HCL 225 mg tablet recall by Watson
- 03/24/2009
Mycophenolate products (Cellcept - mycophenolate mofetil, Myfortic - mycophenolic acid) - Medication Guide Now Required
- 03/20/2009
Insulin Pens and Cartridges - Risk of Blood-Borne Disease Transmission with Shared Use
- 02/27/2009
Metoclopramide (Reglan, generic) - Black Box Warning for Tardive Dyskinesia
- 02/23/2009
Zonisamide (Zonegran® and Generics) - Risk of Metabolic Acidosis
- 02/20/2009
Efalizumab (Raptiva) and Progressive Multifocal Leukoencephalopathy (Update)
- 02/10/2009
Ethex Recalls Additional Products More Than 60 Drug Products-Update
- 02/09/2009
Vecuronium Bromide for Injection Recall by Hospira
- 02/05/2009
Drotrecogin alfa [activated] (Xigris) - Ongoing Safety Review
- 01/29/2009
Venom Hyperdrive dietary supplement contains undeclared sibutramine
- 01/14/2009
Ultram ER Voluntary Recall
- 01/12/2009
Ezetimibe/Simvastatin versus Simvastatin Alone (ENHANCE) of Ongoing Data Review
- 01/05/2009
Tramadol injection - Typographical Error in the Handbook on Injectable Drugs
- 01/02/2009
Fentanyl 50 mcg/hour Transdermal System Recall (Duragesic - Janssen, generic - Sandoz)
- 12/31/2008
Tinzaparin - Increased Risk of Mortality - Ongoing Safety Analysis
- 12/24/2008
Hydromorphone 2 mg Tablet Recall by Ethex
- 12/24/2008
KV Pharmaceutical Tablet Shipment Suspension
- 12/12/2008
Oral Sodium Phosphate Products for Bowel Cleansing - Renal Adverse Effects
- 12/12/2008
Advanced Medical Optics Recall - Healon D Ophthalmic Viscosurgical Device
- 12/09/2008
Hospira Recall - Potassium 20 mEq in 5% Dextrose/ 0.45% Sodium Chloride
- 12/01/2008
STARCAPS Diet System Capsules May Contain Bumetanide
- 12/01/2008
Zhen De Shou Dietary Supplement Contains Undeclared Sibutramine
- 11/25/2008
Phenytoin and Fosphenytoin - Skin Reactions More Common in Patients with the Human Leukocyte Antigen Allele, HLA*B 1502.
- 11/21/2008
Corvalol - Unapproved Drug Contains Phenobarbital
- 11/18/2008
Benzoyl Peroxide 10% Topical Acne Gel - Product Recall
- 11/13/2008
Infants' Mylicon Gas Relief Dye Free Drops Recall
- 11/13/2008
Bisphosphonates of Safety Review of FDA Early Communication Regarding Atrial Fibrillation
- 11/07/2008
Insulin Syringe (ReliOn) Recall
- 10/17/2008
Dextroamphetamine sulfate 5 mg tablets by Ethex recall
- 10/10/2008
Cough and Cold Medications Update - Infant Deaths and Use in Children UPDATED
- 10/08/2008
Tiotropium (Spiriva) and Risk of Stroke - Ongoing Safety Review UPDATED
- 09/30/2008
HMG-CoA-reductase inhibitors do not increase incidence of amyotrophic lateral sclerosis (AML)
- 09/30/2008
Epoetin alfa (Eprex) in the Treatment of Acute Ischemic Stroke
- 09/25/2008
Ammonul (sodium phenylacetate and sodium benzoate) Injection - Filter Required
- 09/24/2008
Erlotinib (Tarceva) and Hepatic Dysfunction
- 09/19/2008
Phosphocol P 32 - Increased Risk of Leukemia and Radiation Injury
- 08/20/2008
Exenatide (Byetta) and Pancreatitis
- 08/11/2008
Simvastatin products (Zocor, Zetia, Simcor, generic) and Amiodarone (Cordarone, Pacerone, generic) - Potentially Serious Interaction
- 08/05/2008
Actavis Drug Recall
- 07/30/2008
Mitoxantrone (Novantrone) - Cardiac Monitoring
- 07/29/2008
Abacavir (Ziagen) and Abacavir-Containing Medications - Patient Screening Recommended
- 07/25/2008
Human Papillomavirus Recombinant Quadrivalent Vaccine, Types 6, 11, 16, 18 (Gardasil®) -Safety Update
- 07/17/2008
Micro-bubble Perflutren Contrast Agents (Definity and Optison) Associated with Deaths and Serious Cardiopulmonary Reactions
- 07/17/2008
Sodium Polystyrene Sulfonate - Recall Due to Contamination with Yeast
- 07/14/2008
Bevacizumab (Avastin®) and sunitinib (Sutent®) – combined use may increase risk of microangiopathic hemolytic anemia
- 07/11/2008
Trastuzumab (Herceptin) and Bacteriostatic Water for Injection Diluent Vials - Potential Vial Damage
- 07/09/2008
Nifedipine (Nifediac™ CC) Extended Release Tablets- Recall
- 07/09/2008
Fluoroquinolones and Tendinitis and Tendon Rupture
- 07/02/2008
Chlorhexidine Gluconate Skin Preparation Cloth - Recall
- 06/30/2008
Mycophenolate Mofetil (CellCept) and Mycophenolate Acid (Myfortic) and risk of Progressive Multifocal Leukoencephalopathy - Ongoing Safety Reviewd
- 06/27/2008
Cyclopentolate and Tropicamide Administration Errors
- 06/18/2008
Heparin - Voluntary Recall of Baxter Heparin Vials, B. Braun Heparin Large Volume Infusion Bags, and Covidien (Kendall) Heparin Flush Prefilled Syringes
- 06/16/2008
Conventional and Atypical Antipsychotics-Increased Risk of Death in Elderly Patients Taking Antipsychotics for Dementia-Related Psychosis
- 06/10/2008
Becaplermin Gel (Regranex) and Risk of Cancer Death - Ongoing Safety Review
- 06/04/2008
Calcilo XD Infant Formula - Product Recall
- 05/30/2008
Mommy's Bliss Nipple Cream - Harmful Ingredients for Nursing Babies
- 05/21/2008
Minocycline (Solodyn) - Two lots recalled due to product mix-up
- 05/16/2008
Mycophenolate Mofetil (Cellcept) and Mycophenolic Acid (Myfortic) and Birth Defect Risk
- 05/07/2008
Alcohol-Free Mouthwash - Recall
- 05/02/2008
Etanercept (Enbrel) Black Box Warning of Infection Risk
- 04/29/2008
Actavis Totowa Digoxin (Digitek®) Recall
- 04/24/2008
Hydrocodone Long-Acting Antitussives (Tussionex) - Safe Use
- 04/10/2008
Inhaled Insulin (Exubera) and Lung Cancer
- 04/10/2008
Daptomycin (Cubicin) - MBT Contaminant When Stored in ReadyMED Elastomeric Pump
- 04/03/2008
Tegaserod (Zelnorm) - Discontinued, No Longer Available Through Treatment Investigational New Drug Protocol- UPDATE
- 04/03/2008
Neuraminidase Inhibitors, Oseltamivir Phosphate (Tamiflu) and Zanamivir (Relenza), Associated with Neuropsychiatric Events
- 03/25/2008
Sargramostim (Leukine) Liquid Formulation Withdrawn from Market; Special Access Program for Powder Formulation
- 03/14/2008
Erythropoiesis-Stimulating Agents (Darbepoetin alfa [Aranesp], Epoetin alfa [Epogen, Procrit]) - Revised Black Box Warnings-Update
- 03/14/2008
Darunavir (Prezista)- Hepatotoxicity Warnings
- 03/11/2008
Icy Hot Heat Therapy Products - Recall
- 03/07/2008
Unapproved and Misbranded Drugs for Prevention and Treatment of STDs Marketed over the Internet
- 03/06/2008
Immune Globulin (GamaSTAN S/D™) - Uncalibrated Syringes
- 03/04/2008
Correct Use of Tiotropium Bromide (Spiriva) and Formoterol Fumarate (Foradil) Capsules
- 03/04/2008
Fentanyl Transdermal System Recall (Actavis, Abrika)
- 03/04/2008
Measles, Mumps, Rubella, and Varicella Vaccine (ProQuad) - Ongoing Safety Review
- 02/29/2008
Natalizumab (Tysabri) - Reports of Liver Injury after Natalizumab Use
- 02/25/2008
Rabies Immune Globulin (HyperRAB S/D) - Uncalibrated Syringes
- 02/19/2008
Fentanyl 25 mcg/hour Transdermal System Recall (Duragesic - Janssen, generic - Sandoz)
- 02/06/2008
FDA Bans the Manufacture of Unapproved Injectable Colchicine Products
- 02/01/2008
NuCel Labs “Eye Drops” and “Eye/Ear Wash” Recalled
- 01/23/2008
Heparin Lock Flush Pre-filled Syringes and Normal Saline Pre-filled Flush Syringes Recalled by AM2 PAT, Inc.
- 01/23/2008
Ortho Evra® (norelgestromin/ethinyl estradiol) Labeling Update
- 01/22/2008
Edetate Disodium - Sound-Alike Confusion with Edetate Calcium Disodium
- 01/11/2008
Bioidentical Hormone Replacement Therapy - Misleading Information
- 01/08/2008
Bisphosphonates (alendronate [Fosamax, Fosamax plus D], etidronate [Didronel], ibandronate [Boniva], pamidronate [Aredia], risedronate [Actonel, Actonel and calcium], tiludronate [Skelid], zoledronic acid [Reclast, Zometa]) - Bone, Joint, and Musculoskeletal Pain Reminder
- 12/24/2007
Fentanyl Transdermal Patch (Duragesic, generics) - Cautions About Safe and Appropriate Use
- 12/14/2007
Deferasirox (Exjade) - Potentially Fatal Renal, Hepatic, Hematologic, and Allergic Events
- 12/12/2007
Carbamazepine (Tegretol) - Skin Reactions More Common in Patients with Human Leukocyte Antigen B*1502 Allele
- 12/12/2007
Omeprazole (Prilosec/Zegerid/generic) and Esomeprazole (Nexium) - Possible Association with Cardiac Events
- 12/06/2007
Desmopressin - Risk of Hyponatremia and Seizures
- 11/27/2007
Mycophenolate Products (Cellcept, Myfortic) - Pregnancy Risk Category Updated
- 11/5/2007
Aprotinin (Trasylol) Marketing Temporarily Suspended Pending Ongoing Safety Review
- 11/2/2007
NC Solution, and other Products by General Therapeutics Corp. Seized
- 10/25/2007
Modafanil (Provigil) - Rash and Psychiatric Warnings
- 10/11/2007
Cochlear Implant Device Increases Risk of Pneumococcal Meningitis - Immunization Recommended
- 9/28/2007
Hydrocodone Antitussives - FDA Halts Marketing of Unapproved Products
- 9/28/2007
Fentanyl Buccal Tablet (Fentora®) - Inappropriate Use Causes Death/Adverse Effects
- 9/28/2007
Medicaid Tamper-Resistant Requirement - Delayed 6 Months
- 9/28/2007
Baby's Bliss Gripe Water by MOM Enterprises Recalled
- 9/19/2007
B. Braun Normal Saline Flush Recall
- 9/19/2007
Haloperidold Labeling Regarding Risk of Torsades de Pointes and QT Prolongation
- 9/14/2007
Nelfinavir Mesylate (Viracept) - New Impurity Specifications
- 9/13/2007
Abbott Blood Glucose Meter Display Problems
- 9/7/2007
Daytrana™ (Methylphenidate Transdermal System) Recall
- 8/27/2007
National Provider Identifier (NPI) - Personal Information Alert
- 8/22/2007
METABOSLIM Dietary Supplement Contains Undeclared Sibutramine
- 8/20/2007
Entecavir (Baraclude) and Possible HIV Resistance
- 8/20/2007
Warfarin - Pharmacogenomic Labeling Changes
- 8/17/2007
Codeine use in Nursing Mothers with a Specific CYP2D6 Genotype may lead to Morphine Overdose in the Nursing Infant
- 8/16/2007
Omega-3-acid Ethyl Esters Brand Name Changed from Omacor to Lovaza
- 8/15/2007
Lopinavir/Ritonavir Oral Solution (Kaletra) - Potential Risk of Overdose in Children
- 8/15/2007
Rosiglitazone (Avandia) and Pioglitazone (Actos) - Stronger Warnings about Heart Failure
- 8/14/2007
Red Yeast Rice Supplements 5/Contain Lovastatin
- 8/8/2007
Tigecycline (Tygacil®) Reformulation
- 7/9/2007
Ertapenem Sodium (Invanz) Recall
- 7/5/2007
Oxycodone Extended-Release Tablets From Endo, Dava, and Watson - Discontinued
- 7/3/2007
Omalizumab (Xolair) - Reports of Delayed Anaphylaxis
- 7/2/2007
Colistimethate (Coly-Mycin M®, generics) Inhalation Possibly Associated With Death
- 6/19/2007
Live Oral Pentavalent Rotavirus Vaccine (RotaTeq) - Reports of Kawasaki Disease
- 6/19/2007
Propofol (Diprivan/generics) - Adverse Events Resembling Bacterial Sepsis
- 5/30/2007
Infant Formula with Iron Recall - Abbott Similac Special Care 24 Cal/fl. oz. Ready-to-Feed Premature
- 5/30/2007
Advanced Medical Optics Contact Lens Solution Recall
- 5/22/2007
Caffeine Citrate Powder/Purified - Recall
- 5/11/2007
OxyContin (oxycodone extended-release) manufacturer pleads guilty to misbranding and misrepresenting product
- 5/7/2007
Antidepressants and Suicidality in Young Adults
- 5/3/2007
Colchicine Injection - Recall of Compounded Product
- 5/3/2007
Counterfeit Medications on the Internet - FDA Warning about Orlistat (Xenical)
- 4/27/2007
PharmaFab to Stop Manufacturing Unapproved Drugs
- 4/24/2007
Bevacizumab (Avastin) and Tracheoesophageal Fistula
- 4/12/2007
Tizanidine (Zanaflex) - Contraindicated with Fluvoxamine or Ciprofloxacin
- 4/12/2007
Alglucosidase Alfa (Myozyme) - Formation of Black Particles During Reconstitution
- 4/12/2007
Griseofulvin (Grifulvin V) Oral Suspension - Recall
- 4/12/2007
Abacavir Sulfate (Ziagen) and Lamivudine/Zidovudine (Combivir) - Third Party Tampering
- 4/9/2007
Trimethobenzamide Suppositories - Discontinued Due to Lack of Efficacy
- 3/30/2007
Pergolide Products Withdrawn From Market Due to Heart Valve Damage
- 3/29/2007
Isotretinoin (Accutane, generic) - New Informational FDA web site
- 3/27/2007
Telithromycin (Ketek) Updated Warnings
- 3/19/2007
Linezolid (Zyvox®) - Increased Mortality Following Treatment of Intravascular Catheter-Related Infections
- 3/15/2007
Sedative-Hypnotic Labeling Revisions
- 3/9/2007
Interferon Gamma-1b (Actimmune) - Early Termination of Trial for Idiopathic Pulmonary Fibrosis
- 3/9/2007
Pioglitazone (Actos/Actoplus Met/Duetact) and Rosiglitazone (Avandia/Avandamet/Avandaryl) Increased Fracture Risk
- 3/7/2007
Salivart Oral Moisturizer Recall
- 3/5/2007
Ergotamine – FDA Halts Marketing of Unapproved Products
- 2/26/2007
Mycophenolate Mofetil (Cellcept) Plus Sirolimus (Rapamune) - Increased Acute Rejection In Cardiac Transplant Patients
- 2/23/2007
Hyperactivity Medications: Patient Medication Guide Required due to Cardiovascular and Psychiatric Adverse Effects
- 2/21/2007
Mislabeled Internet Medications - Dangerous Ingredients
- 2/20/2007
Erythropoiesis-Stimulating Agent (Darbepoetin alfa [Aranesp]) Increases Death in Non-Chemotherapy-Induced Anemia
- 2/20/2007
Live Oral Pentavalent Rotavirus Vaccine (RotaTeq) - Post-Marketing Reports of Intussusception
- 2/12/2007
Heparin Administration Errors - Use of Incorrect Concentrations
- 2/2/2007
Daptacel (DTaP) and Adacel (Tdap) Administration Errors
- 2/2/2007
Ranibizumab (Lucentis®) 0.5 mg Increases Stroke RiskD
- 1/2/2007
Floranex (Lactobacillus) and Florinef (fludrocortisone) Name Confusion
- 12/18/2006
Aprotinin (Trasylol): Increased Risk Of Myocardial Infarction/Stroke/Renal Dysfunction/and Anaphylaxis
- 12/14/2006
Ketamine HCl (Ketalar) 10mg/mL Injection - Recall
- 12/13/2006
Quinine Sulfate - FDA Orders Halt of the Sale of Unapproved Products
- 12/12/2006
Heparin -Induced Thrombocytopenia - Delayed-Onset Warning
- 11/28/2006
Methadone Hydrochloride (Dolophine, generics) - Cardiac and Respiratory Deaths
- 11/20/2006
Epoetin alfa/Darbepoetin alfa: Hemoglobin Target above 12 g/dL Increases Cardiovascular Risk
- 11/10/2006
Acetaminophen 500 mg Tablets (Store Brands) - Recall
- 10/30/2006
Venlafaxine (Effexor®/Effexor XR®) - Overdose Risk
- 10/24/2006
Meningococcal Conjugate Vaccine (Menactra) Associated with Guillain Barré Syndrome
- 10/19/2006
Imatinib Mesylate (Gleevec®) - Cardiac Events
- 10/17/2006
OneTouch® Blood Glucose Test Strips - Counterfeit Alert
- 10/16/2006
DEA Numbers 5/Begin With Letter "F"
- 10/12/2006
Accutane and Generic Isotretinoin - iPLEDGE Risk Management Program Modification
- 10/11/2006
Warfarin Sodium (Coumadin®) - Patient Medication Guide and Black Box Warning
- 10/08/2009
Paroxetine (Paxil®/Paxil CR®) Labeling Changes - Suicidality in Adults
- 10/3/2006
Lamotrigine (Lamictal) During Pregnancy 5/Increase Risk of Cleft Lip or Cleft Palate
- 9/27/2006
Bevacizumab (Avastin®) and Risk of Reversible Posterior Leukoencephalopathy Syndrome (RPLS) and Nasal Septum Perforation
- 9/21/2006
Norelgestromin/ethinyl estradiol patch (Ortho Evra) May Increase Blood Clot Risk
- 9/14/2006
Ibuprofen and Aspirin Drug Interaction
- 9/7/2006
Ephedrine alkaloids in dietary supplements illegal to market in US
- 9/7/2006
Famotidine and Lorazepam Administration Errors
- 8/22/2006
Dextroamphetamine (Dexedrine/Dexedrine Spansule) Labeling Changes/Including Sudden Death
- 8/18/2006
Hydralazine HCl 20mg/mL Injection - Recall
- 8/11/2006
Unapproved Compounded Inhalation Solutions May Not Be Safe
- 8/7/2006
Lamisil (Terbinafine) and Lamictal (Lamotrigine) Name Confusion
- 8/2/2006
Kaopectate and Generic Kaolin-Pectin Products - Reformulation
- 8/2/2006
Vapor Patch Voluntary Recall - Triaminic Vapor Patch and WellPatch Cough & Cold Soothing Vapor Pads
- 7/25/2006
Iopromide 370 mg/mL Injection (Ultravist) Recall
- 7/25/2006
Bismacine Injection (Chromacine) - Avoid Use for Lyme Disease
- 7/20/2006
SSRI Treatment During Pregnancy
- 7/20/2006
Serotonin Syndrome With Triptans Plus SSRIs or SNRIs
- 7/6/2006
Tipranavir (Aptivus) Associated With Intracranial Hemorrhage
- 6/9/2006
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors) Associated with Birth Defects in First Trimester
- 6/6/2006
Natalizumab (Tysabri) - Resumed Marketing With a Special Restricted Distribution Program
- 5/5/2006
Recall of Goldline Brand Extra-Strength Acetaminophen 500 mg (Genapap/Genebs)
- 4/14/2006
Contact Lens Solutions: Fungal Eye Infections in Soft Contact Lens Wearers
- 4/7/2006
Pegaptanib Sodium Injection (Macugen): Labeling Changes Due to Reports of Anaphylaxis and Angioedema
- 3/31/2006
Diazepam Rectal Gel (Diastat Acudial): Applicator Defect 5/Prevent Delivery of Complete Dose.
- 3/20/2006
Mifepristone (Mifeprex/RU-486) associated with serious infection and bleeding
- 3/17/2006
Denileukin diftitox (Ontak) 5/Cause Visual Loss
- 3/14/2006
Steroid Products Sold Illegally as Dietary Supplements
- 3/6/2006
Salagen (pilocarpine) and Selegiline (Eldepryl) Name Confusion
- 3/3/2006
Bosentan (Tracleer) 5/Cause Hepatotoxicity
- 3/2/2006
Amicar (aminocaproic acid) and Omacor (omega-3-acid ethyl esters) Dispensing Errors
- 2/24/2006
Infant Formula by Gentlease Recalled
- 2/17/2006
Quinolones and Blood Glucose Abnormalities (Hypoglycemia/Hyperglycemia)
- 2/17/2006
Gatifloxacin (Tequin) and Blood Glucose Abnormalities/Contraindicated in Diabetics
- 2/16/2006
Conjugated Estrogen Products (Premarin, Prempro, and Premphase)
- 2/15/2006
Balanced Salt Solution by Cytosol Labs Recalled
- 1/26/2006
Hydroxyurea (Droxia, Hydrea, generic) Associated Cutaneous Vasculitic Toxicities
- 1/24/2006
Potential Cancer Risk With Topical Pimecrolimus (Elidel) and Tacrolimus (Protopic) - Updated
- 1/23/2006
ACCU-CHEC glucose meter device recall
- 1/19/2006
Brazilian Diet Pills 5/Contain Chlordiazepoxide/Fluoxetine/or Stimulants
- 1/19/2006
Amantadine (Symmetrel, generic) and Rimantadine (Flumadine, generic) - High Levels of Resistance By Influenza A H3N2 Viruses
- 1/13/2006
Clozapine (Clozaril, generic) Labeling Changes - White Blood Cell Count Monitoring Changes
- 10/8/2009
Recombinant Factor VIIa (NovoSeven) - Increased Risk of Arterial Thromboembolic Events
- 10/08/2009
Rho(D) Immune Globulin Intravenous (WinRho) - Hematologic Safety Reports
- 1/12/2006
Rosiglitazone (Avandia, Avandamet, Avandaryl) - New Onset or Worsening Macular Edema
- 1/10/2006
Nalbuphine (Nubain) - Use During Labor and Delivery
- 1/3/2006
Fraudulent Avian Flu Therapies - Potentially harmful or 5/interfere with conventional treatments
- 12/15/2005
Methotrexate Injection From Bedford Recalled Due to Ethylene Glycol Content
- 12/13/2005
Clarithromycin (Biaxin/Biaxin XL)- study shows increased cardiovascular mortality
- 12/8/2005
Paxil and Paxil CRd Pregnancy Precautions
- 12/2/2005
Epoetin Alfa (Epogen®/Procrit®) and Darbepoetin Alfa (Aranesph®) - Associated with Pure Red Cell Aplasia
- 12/2/2005
MBI Ordered to Cease Manufacturing and Distributing Products
- 12/2/2005
Alemtuzumab (Campath) Associated with Severe Idiopathic Thrombocytopenic Purpura in Multiple Sclerosis Trials
- 11/23/2005
Tamsulosin (Flomax) Associated with Intraoperative Floppy Iris Syndrome
- 11/23/2005
GenTeal Gel and GenTeal GelDrops Artificial Tears Recall (Novartis Ophthalmics)
- 11/18/2005
Long-Acting Beta 2-Agonists Can Increase Severe Asthma Episodes
- 11/15/2005
Ortho Evra (norelgestromin/ethinyl estradiol): higher estrogen exposure than oral contraceptives
- 11/15/2005
Alefacept (Amevive) not recommended for HIV patients
- 11/4/2005
Morphine Extended Release (Avinza) – Alcohol may cause dose-dumping
- 10/28/2005
Pemoline (Cylert, generic) Products Withdrawn from Market due to Risk of Liver Toxicity
- 10/3/2005
Atomoxetine (Strattera) - Increased Risk of Suicidal Ideation in Pediatric Patients
- 9/28/2005
Toprol-XL® (metoprolol succinate) extended release tablets – Name confusion
- 9/16/2005
NovoLog Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection/[rDNA origin]) NovoLog (insulin aspart [rDNA origin] injection) - Change in Packaging to Help Prevent Dispensing Errors
- 9/15/2005
Cetuximab (Erbitux) - Additional Monitoring for Electrolyte Abnormalities and Infusion Reactions
- 9/6/2005
Trastuzumab (Herceptin) Increases Risk of Cardiotoxicity
- 8/17/2005
Isotretinoin (Accutane®, generic): New risk management program - iPLEDGE
- 8/4/2005
Recall of Perrigo Infant Drops containing Acetaminophen/Dextromethorphan/or Pseudoephedrine
- 7/20/2005
Efalizumab (Raptiva) associated with hemolytic anemia/thrombocytopenia/and serious infection
- 7/20/2005
New Guidelines For Appropriate Nesiritide (Natrecor) Use
- 7/14/2005
Hydromorphone Extended Release (Palladone) withdrawn for safety reasons
- 7/12/2005
Erectile Dysfunction Drugs and Vision Loss
- 7/12/2005
Fentanyl (Duragesic, generic) Boxed Warnings
- 7/7/2005
Eli Lilly Discontinuing Humulin U Ultralente/Humulin L Lente/Regular Iletin II/and NPH Iletin II Insulin Products
- 7/1/2005
Antidepressants and Suicidality in Adults to be Evaluated
- 6/17/2005
Gefitinib (Iressa) - shows no survival benefit for non-small cell lung cancer/use discouraged.
- 6/16/2005
COX-2 Selective Inhibitors and NSAIDs - Patient Medication Guide Requirement
- 6/13/2005
Efavirenz (Sustiva) - Pregnancy Risk has Changed to Category D (positive evidence of fetal risk).
- 6/6/2005
Children's Tylenol Meltaways 80 mg/Children's Tylenol SoftChews 80 mg/and Junior Tylenol Meltaways 160 mg - recalled due to confusing packaging and labeling
- 5/25/2005
Dextromethorphan abuse associated with death
- 5/25/2005
Mitoxantrone (Novantrone) - Cardiotoxicity and Secondary Acute Myelogenous Leukemia (AML) in Patients with Multiple Sclerosis
- 5/20/2005
Nesiritide (Natrecor) may adversely effect short-term survival and kidney function in patients with decompensated heart failure
- 5/20/2005
Albumin considered safe for use in critically ill patients
- 5/20/2005
Pamidronate and Zoledronic acid - reports of jaw osteonecrosisD
- 4/29/2005
Drotrecogin alfa (Xigris) Not Effective in Pediatric Patients with Severe Sepsis
- 4/25/2005
Promethazine (Phenergan) injection classified as vesicant
- 4/25/2005
Oxcarbazepine (Trileptal) may cause serious skin and multiorgan hypersensitivity reactions
- 4/25/2005
Interferon beta-1b (Betaseron) may cause hepatotoxicity
- 4/25/2005
Galantamine brand name changed to Razadyne
- 4/12/2005
Atypical Antipsychotics - increased mortality in elderly patients with dementia
- 4/7/2005
Adverse Effects of NSAIDs - Valdecoxib withdrawn/labeling changes for all NSAIDs
- 4/5/2005
Galantamine (Reminyl) - possible increased mortality in patients with mild cognitive impairment
- 3/31/2005
Nefazodone 50 mg/100 mg/150 mg/200 mg/and 250 mg Tablets Recall (Ivax Pharmaceuticals)
- 3/23/2005
Changes to CII prescribing - Postdating no longer allowed
- 3/22/2005
Gabapentin 100 mg capsules (Neurontin) - Recall
- 3/18/2005
Drotrecogin alfa (Xigris) may increase mortality in single organ dysfunction patients
- 3/17/2005
Interferon beta-1a (Avonex, Rebif) – Reports of serious hepatic injury
- 3/10/2005
Bisphosphonate-Induced (Pamidronate [Aredia] and zoledronate [Zometa]) Renal Dysfunction in Oncology Practice
- 3/3/2005
Rosuvastatin (Crestor) - Myopathy and Rhabdomyolysis in Asian-Americans at 40 mg Dose
- 2/23/2005
Tiagabine (Gabitril) can cause seizures in patients without epilepsy
- 2/18/2005
Promethazine (Phenergan, generic) and Fatal Respiratory Depression In Children Under 2 Years of Age – Use Contraindicated
- 2/17/2005
Changes to CII prescribing - FAQ
- 2/10/2005
Methylphenidate hydrochloride 2.5 mg, 5 mg, and 10 mg Chewable Tablets (Methylin CT) – Recall Update
- 2/10/2005
Saquinavir (Fortovase, Invirase) plus ritonavir (ritonavir boosted saquinavir) interacts with rifampin – increased liver toxicity reported
- 2/10/2005
Anagrelide (Agrylin) exposure increased in patients with hepatic impairment, contraindicated in severe hepatic impairment
- 2/10/2005
Name confusion with Zyprexa (olanzapine) and Zyrtec (cetirizine HCl) may lead to medication errors
- 2/10/2005
Amphetamine/Dextroamphetamine (Adderall/Adderall XR)associated with sudden death/sales suspended on Canadian market
- 1/20/2005
Nevirapine (Viramune®) - Risk factors for liver toxicity
- 1/14/2005
Aranesp (darbepoetin alfa) and Adverse Effects with Off-Label Dosing
- 1/13/2005
Amiodarone hydrochloride tablets (Cordarone®/generic) - Patient Medication Guide Requirement
- 1/5/2005
Avastin (bevacizumab) increased risk of arterial thromboembolic events
- 12/22/2004
Infliximab (Remicade) associated with hepatotoxicity
- 12/22/2004
Atomoxetine (Strattera) associated with liver toxicity
- 12/21/2004
Naproxen (Aleve/Anaprox/Naprelan/Naprosyn) cardiovascular risk
- 12/21/2004
Celecoxib (Celebrex) cardiovascular risk
- 12/14/2004
Valdecoxib (Bextra®) cardiovascular risk and severe skin reactions
- 12/1/2004
Bicillin C-R and Bicillin L-A (penicillin G benzathine suspension) – Inappropriate Use for Syphilis
- 11/22/2004
Medroxyprogesterone acetate injection (Depo-Provera® Contraceptive Injection) reduces bone mineral density
- 11/9/2004
Adalimumab (Humira) and infections/hypersensitivity/and hematologic reaction
- 10/15/2004
Antidepressants and suicidality in children: FDA requests labeling change
- 10/15/2004
Tumor Necrosis Factor (TNF) α Blocking Agents - Increased Risk of Lymphoma and Other Malignancies
- 10/11/2004
Rituximab (Rituxan) and Hepatitis
- 10/6/2004
Levoxyl labeling changes – risk of choking, gagging, and dysphagia
- 9/30/2004
Rofecoxib (Vioxx®) withdrawn due to cardiovascular risk
- 9/27/2004
Pantoprazole (Protonix) I.V. glass vial breakage
- 9/2/2004
Shipment of Chiron's Influenza Virus Vaccine (Fluvirin) Delayed
- 9/1/2004
Atypical antipsychotics and hyperglycemia — Aripiprazole (Abilify) clozapine (Clozaril), olanzapine (Zyprexa), quetiapine (Seroquel), risperidone (Risperdal), and ziprasidone (Geodon)
- 8/25/2004
Infliximab (Remicade) and CNS manifestations
- 8/19/2004
Lantus (insulin glargine [rDNA origin] injection recall Lot 40D024/Lot 40D025/Lot 40D027)
- 8/17/2004
Enoxaparin (Lovenox) adjust dose for severe renal impairment
- 8/11/2004
Altocor® (lovastatin extended release) withdrawal/replaced by Altoprev®
- 7/6/2004
Antidepressant labeling changes
- 5/14/2004
Children’s Motrin (ibuprofen) chewable tablets may contain Tylenol (acetaminophen) – packaging error
- 5/12/2004
Trazodone (Desyrel, generic) interactions with CYP3A4 inhibitors and carbamazepine
- 5/5/2004
Quetiapine (Seroquel) 25 mg tablet recall Lot 3446J
- 4/28/2004
Tegaserod Maleate (Zelnorm®) Associated with Severe Diarrhea and Rare Ischemic Colitis
- 4/27/2004
Dulcolax Brand Products - not all formulations contain bisacodyl
- 4/16/2004
hormone replacement therapy update
- 4/6/2004
Duragesic Patch Recall UPDATE
- 4/6/2004
Human rabies vaccine (Imovax - Aventis Pasteur)
- 2/2/2004
Nevarapine (Viramune) Associated with Potentially-Fatal Hepatotoxicity
- 12/2003
Ziprasidone (Geodon) and Fluoroquinolones – Increased Risk of QT Interval Prolongation with Combined Use
- 12/30/2003
Ephedra – FDA Plans to Ban Sale in Dietary Supplements
- 11/21/2003
Arava (leflunomide) associated with severe infections and potentially fatal hepatic injury
- 11/21/2003
Sevoflurane (Ultane) – Fire Danger when Used with Desiccated Carbon Dioxide Absorbent
- 11/02/2009
Morphine Sulfate 20 mg/mL Concentrated Oral Solution (Roxanol)
- 10/3/2003
FD&C Blue No. 1 Toxicity
- 9/10/2003
Levomethadyl hydrochloride acetate (Orlaam) Discontinued
- 9/3/2003
Actiq (fentanyl transmucosal) lozenges – breaking or shattering during use
- 8/28/2003
Daclizumab (Zenapax) – Updated Adverse Effect Information
- 7/31/2003
Lamivudine (Epivir), Abacavir (Ziagen), and Tenofovir (Viread): Early Virologic Non-Response with Concomitant Use
- 7/2003
norethindrone and ethinyl estradiol tablets (Nortrel)
- 4/2003
Risperidone (Risperdal®) and Risk of Cerebrovascular Events
- 2/25/2003
Pergolide Mesylate (Permax) Associated with Cardiac Valve Disorders
- 11/13/2002
Valdecoxib (Bextra) Associated with Hypersensitivity Reactions
- 10/28/2002
meningococcal polysaccharide vaccine
- 10/14/2002
Medroxyprogesterone Acetate & Estradiol Cypionate Injectable Suspension (Lunelle™) – Product Recall
- 10/04/2002
Mefloquine (Lariam®) contraindicated in patients with a history of psychiatric disorders
- 5/20/2002
Immune Globulin Intravenous (IGIV) May be Associated with Thrombotic Events
- 1/2002
Droperidol (Inapsine) and risk of QT prolongation
Social Media
Copyright © 2014 University of Utah Health Care